James V. Mazzo, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 46,389 shares at $53.28 ($2.5M) on 2011-10-24, disclosed to the SEC on 2011-10-26.
Scheduled sale ($2.5M) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.24 | 1,000 | $53K | 2.2% |
| 2 | $53.25 | 1,200 | $64K | 2.6% |
| 3 | $53.26 | 3,400 | $181K | 7.3% |
| 4 | $53.27 | 100 | $5K | 0.2% |
| 5 | $53.27 | 300 | $16K | 0.6% |
| 6 | $53.28 | 200 |
| $11K |
| 0.4% |
| 7 | $53.28 | 1,226 | $65K | 2.6% |
| 8 | $53.29 | 2,800 | $149K | 6.0% |
| 9 | $53.29 | 1,300 | $69K | 2.8% |
| 10 | $53.30 | 300 | $16K | 0.6% |
| 11 | $53.30 | 4,100 | $219K | 8.8% |
| 12 | $53.31 | 6,196 | $330K | 13.4% |
| 13 | $53.31 | 100 | $5K | 0.2% |
| 14 | $53.31 | 1,000 | $53K | 2.2% |
| 15 | $53.32 | 800 | $43K | 1.7% |
| 16 | $53.32 | 1,500 | $80K | 3.2% |
| 17 | $53.33 | 1,200 | $64K | 2.6% |
| 18 | $53.33 | 3,800 | $203K | 8.2% |
| 19 | $53.34 | 100 | $5K | 0.2% |
| 20 | $53.34 | 900 | $48K | 1.9% |
| 21 | $53.34 | 4,047 | $216K | 8.7% |
| 22 | $53.35 | 2,475 | $132K | 5.3% |
| 23 | $53.36 | 1,700 | $91K | 3.7% |
| 24 | $53.37 | 200 | $11K | 0.4% |
| 25 | $53.38 | 200 | $11K | 0.4% |
| 26 | $53.39 | 1,945 | $104K | 4.2% |
| 27 | $53.40 | 1,500 | $80K | 3.2% |
| 28 | $53.40 | 2,400 | $128K | 5.2% |
| 29 | $53.41 | 400 | $21K | 0.9% |
| Total | $53.32 avg | 46,389 | $2.5M | 100% |
| Filing → |
| ABT | SELL | 2012-02-28 | $57K | — | Filing → |
| ABT | SELL | 2011-10-26 | $2.5M | — | Filing → |
| ABT | SELL | 2011-10-26 | $251K | — | Filing → |